Literature DB >> 23211398

Epigenetic studies of schizophrenia: progress, predicaments, and promises for the future.

Emma Dempster1, Joana Viana, Ruth Pidsley, Jonathan Mill.   

Abstract

Increased understanding about the functional complexity of the genome has led to growing recognition about the role of epigenetic variation in the etiology of schizophrenia. Epigenetic processes act to dynamically control gene expression independently of DNA sequence variation and are known to regulate key neurobiological and cognitive processes in the brain. To date, our knowledge about the role of epigenetic processes in schizophrenia is limited and based on analyses of small numbers of samples obtained from a range of different cell and tissue types. Moving forward, it will be important to establish cause and effect in epigenetic studies of schizophrenia and broaden our horizons beyond DNA methylation. Rather than investigating genetic and epigenetic factors independently, an integrative etiological research paradigm based on the combination of genomic, transcriptomic, and epigenomic analyses is required.

Entities:  

Mesh:

Year:  2012        PMID: 23211398      PMCID: PMC3523917          DOI: 10.1093/schbul/sbs139

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  34 in total

1.  Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder.

Authors:  Hamid Mostafavi Abdolmaleky; Kuang-Hung Cheng; Stephen V Faraone; Marsha Wilcox; Stephen J Glatt; Fangming Gao; Cassandra L Smith; Rahim Shafa; Batol Aeali; Julie Carnevale; Hongjie Pan; Panagiotis Papageorgis; Jose F Ponte; Vadivelu Sivaraman; Ming T Tsuang; Sam Thiagalingam
Journal:  Hum Mol Genet       Date:  2006-09-19       Impact factor: 6.150

2.  Reelin promoter hypermethylation in schizophrenia.

Authors:  Dennis R Grayson; Xiaomei Jia; Ying Chen; Rajiv P Sharma; Colin P Mitchell; Alessandro Guidotti; Erminio Costa
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-16       Impact factor: 11.205

3.  The DNA methylation profile within the 5'-regulatory region of DRD2 in discordant sib pairs with schizophrenia.

Authors:  Ai-ping Zhang; Jian Yu; Ji-xia Liu; Hong-yu Zhang; Ying-ying Du; Jing-de Zhu; Guang He; Xing-wang Li; Niu-fan Gu; Guo-yin Feng; Lin He
Journal:  Schizophr Res       Date:  2007-01-04       Impact factor: 4.939

4.  Epigenomic profiling reveals DNA-methylation changes associated with major psychosis.

Authors:  Jonathan Mill; Thomas Tang; Zachary Kaminsky; Tarang Khare; Simin Yazdanpanah; Luigi Bouchard; Peixin Jia; Abbas Assadzadeh; James Flanagan; Axel Schumacher; Sun-Chong Wang; Arturas Petronis
Journal:  Am J Hum Genet       Date:  2008-03       Impact factor: 11.025

5.  Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report.

Authors:  Hamid Mostafavi Abdolmaleky; Kuang-hung Cheng; Andrea Russo; Cassandra L Smith; Stephen V Faraone; Marsha Wilcox; Rahim Shafa; Stephen J Glatt; Giang Nguyen; Joe F Ponte; Sam Thiagalingam; Ming T Tsuang
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-04-05       Impact factor: 3.568

6.  The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia.

Authors:  S A Lott; P R Burghardt; K J Burghardt; M J Bly; T B Grove; V L Ellingrod
Journal:  Pharmacogenomics J       Date:  2012-03-06       Impact factor: 3.550

7.  DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia.

Authors:  Kazuya Iwamoto; Miki Bundo; Kazuo Yamada; Hitomi Takao; Yoshimi Iwayama-Shigeno; Takeo Yoshikawa; Tadafumi Kato
Journal:  J Neurosci       Date:  2005-06-01       Impact factor: 6.167

8.  Methylation status of the reelin promoter region in the brain of schizophrenic patients.

Authors:  Mamoru Tochigi; Kazuya Iwamoto; Miki Bundo; Atsuko Komori; Tsukasa Sasaki; Nobumasa Kato; Tadafumi Kato
Journal:  Biol Psychiatry       Date:  2007-09-17       Impact factor: 13.382

9.  Monozygotic twins exhibit numerous epigenetic differences: clues to twin discordance?

Authors:  Arturas Petronis; Irving I Gottesman; Peixiang Kan; James L Kennedy; Vincenzo S Basile; Andrew D Paterson; Violeta Popendikyte
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

10.  The quantification of COMT mRNA in post mortem cerebellum tissue: diagnosis, genotype, methylation and expression.

Authors:  Emma L Dempster; Jonathan Mill; Ian W Craig; David A Collier
Journal:  BMC Med Genet       Date:  2006-02-16       Impact factor: 2.103

View more
  18 in total

Review 1.  Decoding the non-coding genome: elucidating genetic risk outside the coding genome.

Authors:  C L Barr; V L Misener
Journal:  Genes Brain Behav       Date:  2016-01-04       Impact factor: 3.449

2.  Biomarker Development for Brain-Based Disorders: Recent Progress in Psychiatry.

Authors:  James O Ebot Enaw; Alicia K Smith
Journal:  J Neurol Psychol       Date:  2013-11-01

Review 3.  The epigenome and postnatal environmental influences in psychotic disorders.

Authors:  Ehsan Pishva; Gunter Kenis; Daniel van den Hove; Klaus-Peter Lesch; Marco P M Boks; Jim van Os; Bart P F Rutten
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-02-19       Impact factor: 4.328

4.  DNA methylation meta-analysis reveals cellular alterations in psychosis and markers of treatment-resistant schizophrenia.

Authors:  Eilis Hannon; Emma L Dempster; Georgina Mansell; Joe Burrage; Nick Bass; Marc M Bohlken; Aiden Corvin; Charles J Curtis; David Dempster; Marta Di Forti; Timothy G Dinan; Gary Donohoe; Fiona Gaughran; Michael Gill; Amy Gillespie; Cerisse Gunasinghe; Hilleke E Hulshoff; Christina M Hultman; Viktoria Johansson; René S Kahn; Jaakko Kaprio; Gunter Kenis; Kaarina Kowalec; James MacCabe; Colm McDonald; Andrew McQuillin; Derek W Morris; Kieran C Murphy; Colette J Mustard; Igor Nenadic; Michael C O'Donovan; Diego Quattrone; Alexander L Richards; Bart Pf Rutten; David St Clair; Sebastian Therman; Timothea Toulopoulou; Jim Van Os; John L Waddington; Patrick Sullivan; Evangelos Vassos; Gerome Breen; David Andrew Collier; Robin M Murray; Leonard S Schalkwyk; Jonathan Mill
Journal:  Elife       Date:  2021-02-26       Impact factor: 8.140

5.  High Precision DNA Modification Analysis of HCG9 in Major Psychosis.

Authors:  Mrinal Pal; Sasha Ebrahimi; Gabriel Oh; Tarang Khare; Aiping Zhang; Zachary A Kaminsky; Sun-Chong Wang; Arturas Petronis
Journal:  Schizophr Bull       Date:  2015-06-15       Impact factor: 9.306

6.  Methylomic profiling of human brain tissue supports a neurodevelopmental origin for schizophrenia.

Authors:  Ruth Pidsley; Joana Viana; Eilis Hannon; Helen Spiers; Claire Troakes; Safa Al-Saraj; Naguib Mechawar; Gustavo Turecki; Leonard C Schalkwyk; Nicholas J Bray; Jonathan Mill
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

7.  Olanzapine induced DNA methylation changes support the dopamine hypothesis of psychosis.

Authors:  Melkaye G Melka; Christina A Castellani; Benjamin I Laufer; Raj N Rajakumar; Richard O'Reilly; Shiva M Singh
Journal:  J Mol Psychiatry       Date:  2013-11-04

Review 8.  Epigenetic signaling in psychiatric disorders: stress and depression.

Authors:  Rosemary C Bagot; Benoit Labonté; Catherine J Peña; Eric J Nestler
Journal:  Dialogues Clin Neurosci       Date:  2014-09       Impact factor: 5.986

Review 9.  Recent genetic findings in schizophrenia and their therapeutic relevance.

Authors:  Paul J Harrison
Journal:  J Psychopharmacol       Date:  2014-10-14       Impact factor: 4.153

Review 10.  Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs-Influence of Smoking Behavior and Inflammation on Pharmacokinetics.

Authors:  Nicole Moschny; Gudrun Hefner; Renate Grohmann; Gabriel Eckermann; Hannah B Maier; Johanna Seifert; Johannes Heck; Flverly Francis; Stefan Bleich; Sermin Toto; Catharina Meissner
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.